首页 › 基金 › Nicholas Investment Partners, LP › XENE

Nicholas Investment Partners, LP 对 XENE 的持仓历史

XENON PHARMACEUTICALS INC · 医疗保健

Nicholas Investment Partners, LP 在 Q2 2026 的 13F 申报中披露持有 XENE(XENON PHARMACEUTICALS INC)395,844 股,市值约 US$23.9M,约占其申报组合的 1.50%,在其申报持仓中市值排名第 10 位。 Nicholas Investment Partners, LP 最近 12 个申报季度中有 11 个季度披露了 XENE 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)395.84K 股
申报持仓市值$23.89M
组合权重1.50%
首次申报Q3 2023
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Nicholas Investment Partners, LP 对 XENE 的持仓演变

Nicholas Investment Partners, LP 于 Q3 2023 首次披露 XENE 持仓:854,447 股(约 US$29.2M)。 在 11 次申报中,Nicholas Investment Partners, LP 6 次增持、2 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 395,844 股、市值约 US$23.9M,环比增持 148,743 股。。 持仓曾出现大幅变动:Q1 2024 增持约 91% (随后一个季度股价下跌 9%)、Q1 2025 增持约 493% (随后一个季度股价下跌 7%)、Q4 2025 增持约 104% (随后一个季度股价上涨 30%)。

逐季持仓明细

季度股数金额变化
Q3 2023 854.45K $29.19M 新进
Q4 2023 87.75K $4.04M 减持
Q1 2024 167.93K $7.23M 增持
Q3 2024 14.66K $577.09K 新进
Q4 2024 14.66K $574.59K 持有
Q1 2025 86.97K $2.92M 增持
Q2 2025 68.90K $2.16M 减持
Q3 2025 119.10K $4.78M 增持
Q4 2025 242.99K $10.89M 增持
Q1 2026 247.10K $14.37M 增持
Q2 2026 395.84K $23.89M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 XENE 与 13F 数据

XENE(XENON PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 XENE,申报仓位最大的包括:Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 XENE 的基金

查看 XENE 的全部基金持有人 →

常见问题

How long has Nicholas Investment Partners, LP held XENE?

Nicholas Investment Partners, LP has disclosed XENE holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

What is Nicholas Investment Partners, LP's current position in XENE?

As of Q2 2026, Nicholas Investment Partners, LP holds 395.84K shares of XENE (XENON PHARMACEUTICALS INC), valued at $23.89M, representing 1.50% of its reported portfolio and ranking #10.

Has Nicholas Investment Partners, LP been buying or selling XENE?

In the latest 13F filing (Q2 2026), Nicholas Investment Partners, LP increased its position in XENE.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.